Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
120 hedge funds and large institutions have $322M invested in Enzo Biochem, Inc. in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 11 closing their positions.
3,223% more call options, than puts
Call options by funds: $731K | Put options by funds: $22K
100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 11
36% more capital invested
Capital invested by funds: $237M → $322M (+$85.6M)
34% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 32
10% more funds holding
Funds holding: 109 → 120 (+11)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.58M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
+$3.04M |
| 3 |
EGA
Evermore Global Advisors
Summit,
New Jersey
|
+$2.26M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.95M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$6.7M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.88M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.71M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.95M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.35M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
JP Morgan Chase
New York
| – | -$220K | -26,241 | Closed |
|
|
MCM
127
Maple Capital Management
Montpelier,
Vermont
| – | -$117K | -14,000 | Closed |
|
|
TI
128
Trexquant Investment
Stamford,
Connecticut
| – | -$115K | -13,740 | Closed |
|
129
Group One Trading
Chicago,
Illinois
| – | -$30.9K | -3,318 | Closed |
|
130
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$8K | -1,011 | Closed |
|
ENZ Hedge Fund Activity: Q2 2017 in Review
120 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2017, worth a combined $322M — up 36% from $237M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ENZ positions and 11 closed out — a net gain of 11 holders — while 43 added to existing stakes and 32 trimmed.
The largest buyer was BlackRock, adding an estimated $3.58M. The largest seller was First Light Asset Management, cutting an estimated $6.7M.
- 120 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2017, up from 109 in Q1 2017.
- Funds reported $322M of Enzo Biochem, Inc. stock for Q2 2017, up 36% quarter-over-quarter.
- 22 funds opened new Enzo Biochem, Inc. positions in Q2 2017 and 11 closed out, a net change of +11 holders.
- The largest Enzo Biochem, Inc. buyer in Q2 2017 was BlackRock, an estimated $3.58M added.
- The largest Enzo Biochem, Inc. seller in Q2 2017 was First Light Asset Management, an estimated $6.7M sold.
Based on aggregated 13F filings for Q2 2017.